Urief

Urief

silodosin

Manufacturer:

Eisai
Full Prescribing Info
Contents
Silodosin.
Description

Indications/Uses
Bladder outlet obstruction associated with benign prostatic hyperplasia in patients ≥65 yr.
Dosage/Direction for Use
Adult: 4 mg twice daily.
Take after breakfast and evening meal.
Contraindications
Hypersensitivity.
Special Precautions
Patients with orthostatic hypotension, impaired hepatic and renal function. Concomitant treatment with PDE-5 inhibitors. Patients should be instructed to operate potentially hazardous machinery, such as driving a car, with caution.
Adverse Reactions
Retrograde ejaculation, thirst, diarrhea, loose stools, dizziness on standing up, nasal congestion, light-headed feeling, headache.
Drug Interactions
Elevated plasma concentration with CYP3A4 inhibitors. Diminished ability to regulate blood pressure on standing with hypotensive agents. Enhanced hypotensive effect with PDE-5 inhibitors.
MIMS Class
Drugs for Bladder & Prostate Disorders
ATC Classification
G04CA04 - silodosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.
Presentation/Packing
Form
Urief tab 4 mg
Packing/Price
10 × 10's;3 × 10's
Daftar Gratis untuk melanjutkan membaca
Sumber terlengkap se-Asia untuk informasi medis, referensi klinis, dan pendidikan
Sudah punya akun? Masuk